Innovative Outpatient Procedure Provides New Option for Patients with Prostate Cancer
|
UC San Diego Health is the first and only provider in the region to offer TULSA, a novel, minimally invasive treatment option for patients with prostate cancer. For patients like Mark Nicholson, a patient treated by Moores Member Aditya Bagrodia, MD, TULSA allowed him to avoid traditionally invasive treatments and maintain quality of life.
|
Yu-Wei Chen, MD, MS, Receives KidneyCAN Merit Award |
Congratulations to Moores Member Yu-Wei Chen, MD, MS who received this award at the 2025 Kidney Cancer Research Summit in recognition for his research on HIF-2a RNA expression in clear cell renal cell carcinoma.
|
San Diego Leadership in the Fight Against Cancer: Q&A with Diane Simeone, MD |
Moores Director Diane Simeone spoke with the San Diego Business Journal about San Diego’s unique role in advancing cancer care. She emphasizes not only the power of collaboration across research, clinical care, and industry, but also how Moores, the region’s only NCI-designated Comprehensive Cancer Center, is driving transformative progress in early detection, precision medicine, and access to clinical trials.
|
Media Training Opportunity for Health Sciences Faculty |
On October 2, 2025 from 9:00 a.m. to 10:00 a.m., Health Sciences Communications will offer training on strategies in conducting media interviews, which will target these topics:
|
-
The media relations team, their roles, and how they can support your media relations efforts
- Working with journalists
- How to conduct media interviews
|
Space is limited; RSVP (llopez2@health.ucsd.edu) ASAP.
|
|
|
Registration Now Open: Free Compassionate Communication Workshop Series
|
This free, skills-based program is specially designed for health care professionals, medical educators, and researchers. Through interactive sessions, participants will learn how to communicate with greater compassion—and, in turn, greater effectiveness—with patients, health care teams, medical trainees, and beyond.
|
|
|
FEATURED FUNDING OPPORTUNITIES
|
Funding Opportunities Available on the Moores Cancer Center Website |
Explore curated funding opportunities from federal, non-federal, limited submission and internal sources, tailored to provide support for cancer research at every stage.
|
|
|
| Therapy for stage IV non-small cell lung cancer without driver alterations: ASCO living guideline, version 2025.1
|
Journal of Clinical Oncology
|
Lyudmila Bazhenova, MD (Solid Tumor Therapeutics)
|
|
|
| A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy
|
Louise C. Laurent, MD, PhD (N/A)
|
|
|
| Comparative effectiveness of empiric treatment for helicobacter pylori in a large, diverse population in the United States |
Clinical Gastroenterology and Hepatology
|
Shailja Shah, MD, MPH (Cancer Control)
|
| |
CLINICAL TRIALS OFFICE (CTO) |
|
|
RMCGI102: A Platform Study of RAS(ON) Inhibitors in Patients with Gastrointestinal Solid Tumors
PI: Gregory Botta, MD, PhD
NCT ID: NCT06445062
|
|
|
|
